US2004146487A1PendingUtilityA1
Avidin pseudotyped viral vectors and their use
Est. expiryMar 12, 2021(expired)· nominal 20-yr term from priority
C12N 15/86A61K 48/00C12N 2710/14143
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention pertains to an avidin-pseudotyped virus, and especially baculovirus, useful for delivery of foreign genes etc. The present invention also pertains to vectors comprising respective cassettes for pseudotyping, mammalian gene expression and insect gene expression in baculovirus.
Claims
exact text as granted — not AI-modified1 . An avidin-pseudotyped virus.
2 . A virus according to claim 1 , which is a baculovirus.
3 . A virus according to claim 1 or claim 2 , coated with a biotinylated molecule.
4 . A virus according to any preceding claim, which comprises a foreign gene which has, or is capable of expressing a peptide having, diagnostic or therapeutic utility.
5 . Use of a virus according to claim 4 , for gene therapy.
6 . A vector comprising respective cassettes for pseudotyping, mammalian gene expression and insect gene expression in baculovirus.
7 . A vector according to claim 6 , comprising one or more of: the origin of replication of the Epstein-Barr virus; a gene capable of expressing Epstein-Barr nuclear antigen I; and a foreign gene which has, or is capable of expressing a peptide, having diagnostic or therapeutic utility.
8 . A vector according to claim 6 or claim 7 , additionally comprising an effector gene or a marker gene.
9 . A vector according to any preceding claim, additionally comprising a gene modifying the baculovirus phenotype, e.g. by pseudotyping.
10 . A vector according to claim 9 , wherein the modifying gene is under the control of a promoter functional in insect cells.
11 . A baculovirus comprising the elements of a vector according to any of claims 6 to 10 .
12 . Use of a baculovirus according to claim 11 , for gene therapy.Join the waitlist — get patent alerts
Track US2004146487A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.